Regulatory News

Singapore HSA Updates Guidance on Unregistered Therapeutic Product Import and Supply

In March 2023, HSA updated Guidance on Import and Supply of An Unregistered Therapeutic Product For Patients’ Use.

See Pharma To Market insider: https://www.pharmatomarket.com/singapore-hsa-updates-unregistered-therapeutic-product-import-and-supply-guidance-and-forms/?utm_source=rss&utm_medium=rss&utm_campaign=singapore-hsa-updates-unregistered-therapeutic-product-import-and-supply-guidance-and-forms

Minor revision was made by HSA to the

read more...